arrow
A

Anand Mahadevan

department of radiation oncology
H指数:37
被引数:5,252

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating indeterminate bone lesions and lymph nodes on PSMA-PET: a multidisciplinary consensus algorithm and 1-year implementation results

评估PSMA-PET上不确定的骨病变和淋巴结:一个多学科共识算法及1年实施结果

2026-01-060
PRE
Fiducial tracking fidelity in robotic prostate SBRT: a comparison of a 3-fraction boost following pelvic nodal irradiation and definitive 5-fraction treatment

前列腺SBRT中的基准标记追踪保真度:比较盆腔淋巴结照射后进行的3次分割推量照射与5次分割根治性治疗

2025-10-020
OAAI
Efficacy of Stereotactic Ablative Body Radiotherapy (SABR) in uncommon subtypes of primary kidney cancer: An analysis from the International Radiosurgery Oncology Consortium of the Kidney

立体定向消融体部放射治疗(SABR)在不常见类型原发性肾癌中的疗效:国际肾脏放射外科肿瘤学协作组(International Radiosurgery Oncology Consortium of the Kidney)的分析

2025-09-020
PRE
Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney

包括孤立肾患者在内的原发性肾细胞癌立体定向消融放疗后的长期肾功能预后: 国际肾脏放射外科肿瘤学联合会的报告

2024-12-013
PRE
The Radiosurgery Society Working Groups on GRID, LATTICE, Microbeam, and FLASH Radiotherapies: Advancements Symposium and Subsequent Progress Made

放射外科学会关于GRID、LATTICE、微束和FLASH放射治疗的工作组:进展研讨会及后续取得的进展

2024-10-010
PRE
An international Delphi consensus for pelvic stereotactic ablative radiotherapy re-irradiation
2021-11-0115
OAAI